Cited by 1,411Lipoproteins and Cardiovascular HealthLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Open access

Austin, M A, King, M C, Vranizan, K M, Krauss, R M·1990·Circulation

DOI 10.1161/01.cir.82.2.495

Open this paper in CoChat — free account Open PDF

Abstract

In a community-based study of 301 subjects from 61 nuclear families, two distinct phenotypes (denoted A and B) were identified by nondenaturing gradient gel electrophoretic analysis of low density lipoprotein (LDL) subclasses. Phenotype A was characterized by predominance of large, buoyant LDL particles, and phenotype B consisted of a major peak of small, dense LDL particles. Previous analysis of the family data by complex segregation analysis demonstrated that these phenotypes appear to be inherited as a single-gene trait. In the present study, the phenotypes were found to be closely associated with variations in plasma levels of other lipid, lipoprotein, and apolipoprotein measurements. Specifically, phenotype B was associated with increases in plasma levels of triglyceride and apolipoprotein B, with mass of very low and intermediate density lipoproteins, and with decreases in high density lipoprotein (HDL) cholesterol, HDL2 mass, and plasma levels of apolipoprotein A-I. Thus, the proposed genetic locus responsible for LDL subclass phenotypes also results in an atherogenic lipoprotein phenotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.82.2.495

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Statistical Principles in Experimental Design
Myers, J. L., & Winer, B. J. (1964) · The American Journal of Psychology · doi:10.2307/1419292 · Cited by 8,111
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,895
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,885
Applied linear statistical models : regression, analysis of variance, and experimental designs
Neter, J., Wasserman, W., & Kutner, M. (1974) · Andalas University Repository (Andalas University) · Cited by 2,818
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
The analysis of case-control studies
Breslow, N. E., & Day, N. E. (1980) · International Agency for Research on Cancer eBooks · Cited by 2,415

Flagged first, then by citations

Show all 63 references

Research works printed but not linked: 13

Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial: I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-364
Heiss G, Tyroler HA: Are apolipoproteins useful for evaluat- ing ischemic heart disease? A brief overview of the literature, in Lippel K (ed): Proceeding ofthe Workshop on Apolipoprotein Quantification. National Institutes of Health publication No. (NIH) 83-1266, 1983, pp 7-19
Krauss RM, Lindgren FT, Williams PT, Kelsy SF, Brensike J, Vranizan K, Detre KM, Levy RI: Intermediate density lipo- proteins and coronary artery disease progression in hypercho- lesterolemic men. Lancet 1987;2:62-66
Ernst N, Fisher M, Smith W, Gordon W, Rifkind BM, Little JA, Mishkel MA, Williams DO: The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption: The Lipid Research Clinics Program Prevalence Study. Circulation: 1980;62:41-52
Lindgren FT, Jensen LC, Hatch FT: The isolation and quan- titative analysis of serum lipoproteins, in Nelson GJ (ed): Blood Lipids and Lipoproteins. New York, Wiley Interscience, 1972, pp 181-274
Morton NE, Rao DC, Lalouel JM: Methods in genetic epi- demiology, in Klingberg MA (ed): Contributions to Epidemiol- ogy and Biostatistics. Basel, Karger, vol 4, 1983, pp 62-102
Snedecor GW, Cochran WG: Statistical Methods, ed 6. Ames, Iowa, Iowa State University Press, 1967
SAS Users Guide: Basics, Version 5 Edition.
SAS User Guide: Statistics, Version 5 Edition.
Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangeiwaia S: Triglyceride and Coronary Heart Disease Mortal- ity. The Lipid Research Clinics Follow-up Study presented at the American Heart Association 27th Conference on Cardio- vascular Disease Epidemiology, Chapel Hill, NC, 1987
Steiner G, Schwartz L, Shumak S, Poapst M: The association of increased levels of intermediate density lipoproteins with smoking and coronary heart disease. Circulation 1987; 75:124-130
Swinkels DW, Demacker PNM, Hendricks JCM, van t'Laar A: Low density lipoprotein subfractions and relationship to other risk factors in healthy individuals. Arteriosclerosis 1989; 9:604-613
Krauss RM, Albers JJ, Brunzell JD: An apolipoprotein B- enriched low density lipoprotein subspecies in familial com- bined hyperlipidemia. Clin Res 1983;31:503a

Sorted by citations

Items 601–700 of 1,000

Effects of the Addition of T'ai Chi to a Dietary Weight Loss Program on Lipoprotein Atherogenicity in Obese Older Women
Beebe, N., Magnanti, S., Katkowski, L., Benson, M. C., Xu, F., Delmonico, M. J., & Lofgren, I. E. (2013) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2012.0531 · Cited by 29
“The concentration of LDL-C in the blood, as well as the particle size and density of LDL, contributes to its overall atherogenicty.(7) Two emerging risk factors related to LDL-C are concentration of apolipoprotein B (apo B) and LDL particle size.”
Background
Lipid‐Lowering Efficacy and Safety After Switching to Atazanavir‐Ritonavir‐Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus
Nguyen, S., Eaton, S. A., Bain, A. M., Rahman, A. P., Payne, K. D., Bedimo, R. G., Herrington, J. D., Maclayton, D. O., Rodriguez‐Barradas, M. C., & Busti, A. J. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.3.323 · Cited by 29
“Sex Male 35 (97) Female 1 (3) HIV viral load < 50 copies/ml 32 (89) Comorbidities Hypertension 16 (44) Peripheral artery disease 2 (6) Diabetes mellitus 5 (14) Coronary artery disease 7 (19) Smoking 10 (28) Protease inhibitor before switch Lopinavir-ritonavir 20 (56) Nelfinavir 6 (17) Indinavir 6 (17) Saquinavir 4 (11…”
Background
Relationship between obesity and concentration and composition of low-density lipoprotein subfractions in normoinsulinemic men
Halle, M., Berg, A., Frey, I., König, D., Keul, J., & Baumstark, M. W. (1995) · Metabolism · doi:10.1016/0026-0495(95)90134-5 · Cited by 29
Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo
Jover, A., Corbella, E., Muñoz, A., Millán, J., Pintó, X., Mangas, A., Zúñiga, M., Pedro‐Botet, J., & Hernández‐Mijares, A. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.03.010 · Cited by 30
Thiazolidinediones, dyslipidaemia and insulin resistance syndrome
Sunayama, S., Watanabe, Y., Daida, H., & Yamaguchi, H. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200008000-00009 · Cited by 29
Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients
Dachet, C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05411-b · Cited by 29
Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling
Kotze, M. J., Davis, H., Bissbort, S., Langenhoven, E., Brusnicky, J., & Oosthuizen, C. J. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.1993.tb03821.x · Cited by 29
The Significance of Measuring Non‐HDL‐Cholesterol
Hirsch, G. A., Vaid, N., & Blumenthal, R. S. (2002) · Preventive Cardiology · doi:10.1111/j.1520-037x.2002.00980.x · Cited by 29
Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy
Rizzo, M., Trepp, R., Berneis, K. K., & Christ, E. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0652 · Cited by 29
Acute and delayed effects of prolonged exercise on serum lipoproteins
Baumstark, M. W., Frey, I., & Berg, A. (1993) · European Journal of Applied Physiology · doi:10.1007/bf00634304 · Cited by 29
“The importance of LDL subfractions arises from the fact that coronary angiographic studies have demonstrated a direct correlation between levels of small dense LDL particles and the extent (Austin et al. 1990; Krauss 1991) and progression (Krauss et al.”
Background
High-Density Lipoprotein Cholesterol, Plasma Triglyceride, and Coronary Heart Disease: Pathophysiology and Management
Patsch, W., & Gotto, A. M. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61018-2 · Cited by 29
Hepatic Lipase as a Focal Point for the Development and Treatment of Coronary Artery Disease
Zambon, A., Brown, B. G., Deeb, S. S., & Brunzell, J. D. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34107 · Cited by 29
Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes
Phillips, C. M., Owens, D., Collins, P. B., & TOMKIN, G. H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.033 · Cited by 28
Low density lipoprotein particles are small in patients with coronary vasospasm
Miwa, K. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00250-4 · Cited by 28
The Correlation between Lipids Ratio and Degree of Coronary Artery Stenosis
Yang, D., Liu, X., & Xiang, M. (2011) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/11593480-000000000-00000 · Cited by 28
Apolipoprotein A5 and Hypertriglyceridemia
Charlton-Menys, V., & Durrington, P. N. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.044826 · Cited by 28
Small LDL and Its Clinical Importance as a New CAD Risk Factor: A Female Case Study
Superko, H. R., Nejedly, M., & Garrett, B. C. (2002) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2002.01453.x · Cited by 28
Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena
Gentile, M., Panico, S., Jossa, F., Mattiello, A., Ubaldi, S., Marotta, G., Pauciullo, P., & Rubba, P. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.033 · Cited by 28
Persistence of Low HDL-C Levels After Weight Reduction in Older Men With Small LDL Particles
Katzel, L. I., Coon, P. J., Rogus, E. M., Krauss, R. M., & Goldberg, A. P. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.3.299 · Cited by 28
Self-citation
Characterization of low-density lipoprotein subclasses in children
Arisaka, O., Fujiwara, S., Yabuta, K., Mokuno, H., Mitugi, Y., & Miyake, N. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90292-4 · Cited by 28
Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma
Campos, E. M., Kotite, L., Blanche, P. J., Mitsugi, Y., Frost, P. H., Masharani, U. B., Krauss, R. M., & Havel, R. J. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30142-5 · Cited by 28
Self-citation
Insulin resistance predicts early cardiovascular morbidity in men without diabetes mellitus, with effect modification by physical activity
Hellgren, M. I., Daka, B., Jansson, P., Lindblad, U., & Larsson, C. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314537917 · Cited by 27
“Ultimately, a vicious cycle develops with an increase in small and dense LDL particles, which may cause endothelial damage and induce arteriosclerosis.(32) Furthermore, damaged endothelial cells increase the production of pro-coagulant factors such as fibrinogen associated with pro-thrombotic risk.”
Background
Effects of Peroxisome Proliferator-Activated Receptors, Dietary Fat Intakes and Gene–Diet Interactions on Peak Particle Diameters of Low-Density Lipoproteins
Bouchard‐Mercier, A., Godin, G., Lamarche, B., Përusse, L., & Vohl, M. (2011) · Lifestyle Genomics · doi:10.1159/000324531 · Cited by 27
Effects of Dietary Macronutrients on Plasma Lipid Levels and the Consequence for Cardiovascular Disease
Daoud, E., Scheede‐Bergdahl, C., & Bergdahl, A. (2014) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd1030201 · Cited by 28
“No associations between LDL diameter patterns and smoking, diabetes, or hypertension were observed in this sample [29].”
Pattern and predictors of dyslipidemia in patients with type 2 diabetes mellitus
Karim, M. N., Ahmed, K. R., Bukht, M. S., Akter, J., Chowdhury, H. A., Hossain, S., Anwar, N., Selim, S., Chowdhury, S. H., Hossain, F., et al. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.02.011 · Cited by 29
“Studies demonstrated association between LDL and coronary artery disease (CAD) [13].”
Background
[Ketogenic diets: additional benefits to the weight loss and unfounded secondary effects].
Pérez-Guisado, J. (2008) · PubMed · Cited by 27
Low-Density Lipoprotein Particle Size and Its Regulatory Factors in School Children
Shimabukuro, T., Sunagawa, M., & Ohta, T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031818 · Cited by 27
Is the gender difference in LDL size explained by the metabolic complications of visceral obesity?
Lemieux, I., Pascot, A., Lamarche, B., Prud’homme, D., Nadeau, A., Bergeron, J., & Després, J. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01092.x · Cited by 28
In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy
Geiss, H. C., Bremer, S., Barrett, P. H. R., Otto, C., & Parhofer, K. G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300523-jlr200 · Cited by 27
“Comparison of models with regard to the Akaike information criterion Patient Model A Model B Model C A.W. 3.49 3.32 3.35 F.E. 2.81 2.78 2.82 K.K. 5.16 4.30 4.47 L.B. 2.93 2.85 2.85 S.G. 3.08 2.74 2.79 S.K. 7.15 5.65 5.53 S.P. 2.87 2.84 2.84 Mean SD 4.01 2.59 3.61 1.65 3.63 1.55 P 0.018 for model A vs. model B; P 0.028…”
BackgroundInfluential
LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease
Słowik, A., Iskra, T., Turaj, W., Hartwich, J., Dembinska-Kiec, A., & Szczudlik, A. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00166-7 · Cited by 27
“The LDL-B phenotype is considered the genetic risk factor for ischemic heart disease [14].”
BackgroundResultInfluential
Consistency of genetic inheritance mode and heritability patterns of triglyceride vs. high density lipoprotein cholesterol ratio in two Taiwanese family samples
Chien, K., Hsu, H., Su, T., Yang, C.-Y., & Lee, Y. (2003) · BMC Genetics · doi:10.1186/1471-2156-4-7 · Cited by 27
LDL particle size in subjects with previously unsuspected coronary heart disease: relationship with other cardiovascular risk markers
Sherrard, B., Simpson, H., Cameron, J. D., Wahi, S., Jennings, G., & Dart, A. M. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05920-5 · Cited by 27
Classification of LDL Phenotypes by 4 Methods of Determining Lipoprotein Particle Size
Sninsky, J. J., Rowland, C. M., Baca, A. M., Caulfield, M. P., & Superko, H. R. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31829d9d17 · Cited by 26
Estimation of the low-density lipoprotein (LDL) subclass phenotype using a direct, automated assay of small dense LDL-cholesterol without sample pretreatment
Vandermeersch, A., Ameye, S., Puype, D., Petitjean, D., Buyzere, M. D., & Langlois, M. R. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.05.038 · Cited by 26
Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target
Alpers, D. (2008) · Future Lipidology · doi:10.2217/17460875.3.4.385 · Cited by 27
LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach?
Nesto, R. W. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.1.8 · Cited by 27
Fenofibrate-Induced Hyperhomocysteinaemia
Dierkes, J., Westphal, S., & Luley, C. H. (2003) · Drug Safety · doi:10.2165/00002018-200326020-00002 · Cited by 26
Comparison of Low-Density Lipoprotein Size by Polyacrylamide Tube Gel Electrophoresis and Polyacrylamide Gradient Gel Electrophoresis
Hirany, S. V., Othman, Y., Kutscher, P., Rainwater, D. L., Jialal, I., & Devaraj, S. (2003) · American Journal of Clinical Pathology · doi:10.1309/h4e6ktyufff23hfn · Cited by 26
“A linear scoring system developed by Campos et al6 and Rajman et al26 is based on the relative contribution of each subfraction weighted by the fraction number (1-7); Rainwater et al18 suggested estimating the median diameter, which represents the entire LDL absorbance profile.”
Method
Effect of Insulin and Sulfonylurea Therapy, at the Same Level of Blood Glucose Control, on Low Density Lipoprotein Subfractions in Type 2 Diabetic Patients1
Rivellese, A. A., Patti, L., Romano, G., Innelli, F., Marino, L. D., Annuzzi, G., Iavicoli, M., Coronel, G. A., & Riccardi, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6956 · Cited by 26
HDL-C and Triglyceride Levels: Relationship to Coronary Heart Disease and Treatment with Statins
Gaw, A. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1024207925670 · Cited by 26
“This triad of lipid abnormalities comprises the atherogenic lipoprotein profile [45], which frequently occurs in combination with other disorders that predispose the patient to the development of atherosclerotic disease, including hypertension, insulin resistance, obesity and a procoagulant state [46].”
Background
Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size
Suter, P. M., Marmier, G., Veya-Linder, C., Hänseler, E., Lentz, J. J., Vetter, W., & Otvos, J. D. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.11.023 · Cited by 26
Diabetic LDL inhibits cell-cycle progression via STAT5B and p21waf
Brizzi, M. F., Dentelli, P., Pavan, M., Rosso, A., Gambino, R., Cesaris, M. G. D., Garbarino, G. M., Camussi, G., Pagano, G., & Pegoraro, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13617 · Cited by 26
“Indeed, dm-LDL did not show a significant degree of lipid peroxidation, but was characterized by a decreased cholesterol/apoB ratio and by a density profile showing a subfraction distribution corresponding to the LDL subclass defined as pattern B (49).”
Background
The Interface of Genetics and Public Health: Research and Educational Challenges
Austin, M. A., Peyser, P. A., & Khoury, M. J. (2000) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.21.1.81 · Cited by 26
Self-citation
Apolipoprotein ε2 Allele Is Associated With an Anti-atherogenic Lipoprotein Profile in Children: The Columbia University BioMarkers Study
Isasi, C. R., Shea, S. A., Deckelbaum, R. J., Couch, S. C., Starc, T. J., Otvos, J. D., & Berglund, L. (2000) · PEDIATRICS · doi:10.1542/peds.106.3.568 · Cited by 26
Effects of dietary fat on high-density-lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density-lipoprotein subclass patterns
Williams, P., Dreon, D. M., & Krauss, R. M. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1234 · Cited by 26
Self-citation
Relationship between apolipoprotein E and low density lipoprotein particle size
Zhao, S., Verhoeven, M. H., Vink, J., Hollaar, L., van der Laarse, A., de Knijff, P., & Hooft, F. M. V. '. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90156-o · Cited by 26
Lipoprotein Sub-Fractions by Ion-Mobility Analysis and Its Association with Subclinical Coronary Atherosclerosis in High-Risk Individuals
Aneni, E. C., Osondu, C. U., Cruz, J. D. L., Martin, S. S., Blaha, M. J., Younus, A., Feldman, T., Agatston, A. S., Veledar, E., & Nasir, K. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.40741 · Cited by 25
Dyslipidemia in children with type 2 diabetes vs. obesity
Newfield, R. S., Dewan, A. K., & Jain, S. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00345.x · Cited by 25
Non-LDL-related dyslipidaemia and coronary risk: a case-control study
Assmann, G., Cullen, P., & Schulte, H. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110372640 · Cited by 24
Pleiotropy and Heterogeneity in the Expression of Atherogenic Lipoproteins: The IRAS Family Study
Hokanson, J. E., Langefeld, C. D., Mitchell, B. D., Lange, L. A., Goff, D. C., Haffner, S. M., Saad, M. F., & Rotter, J. I. (2003) · Human Heredity · doi:10.1159/000071809 · Cited by 25
Differentiating the effects of raising low levels of high-density lipoprotein cholesterol versus lowering normal triglycerides: further insights from the veterans affairs high-density lipoprotein intervention trial
Miller, M. J. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01466-1 · Cited by 25
Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis
Vaverková, H., Karásek, D., Novotný, D., Jackuliaková, D., Lukeš, J., Halenka, M., & Frohlich, J. J. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.004 · Cited by 25
“Atherogenic lipoprotein phenotype (small, dense LDL, with elevated triglycerides and low HDL-C) is a characteristic dyslipidemia associated with metabolic syndrome and T2D, which increases the risk of CHD several folds [28].”
Background
The metabolic syndrome: Diagnosis and treatment
Zieve, F. J. (2004) · Clinical cornerstone · doi:10.1016/s1098-3597(04)80093-0 · Cited by 26
Low-density lipoprotein size and cardiovascular prevention
Rizzo, M., & Berneis, K. K. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.08.013 · Cited by 25
“LDL size correlates positively with plasma HDL levels and negatively with plasma triglyceride concentrations, and the combination of small, dense LDL, decreased HDLcholesterol, and increased triglycerides has been called the ‘‘atherogenic lipoprotein phenotype’’ [6].”
Background
Regulation of small dense LDL concentration in Korean and Scottish men and women
Cho, H. K., Shin, G.-J., Ryu, S. K., Jang, Y., Day, S., Stewart, G., Packard, C. J., Shepherd, J., & CASLAKE, M. J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00058-8 · Cited by 25
“revealed that subjects with a LDL profile dominated by small, dense LDL had a three-fold increase in CVD risk [7].”
Background
Effect of Alcohol on Postprandial Lipemia with and without Preprandial Exercise
Suter, P. M., Gerritsen-Zehnder, M., Häsler, E., Gürtler, M., Vetter, W., & Hänseler, E. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719015 · Cited by 24
Hyperlipidemic Subjects Have Reduced Uptake of Newly Absorbed Vitamin E into Their Plasma Lipoproteins, Erythrocytes, Platelets, and Lymphocytes, as Studied by Deuterium-Labeled α-Tocopherol Biokinetics,
Hall, W. L., Jeanes, Y., & Lodge, J. K. (2005) · Journal of Nutrition · doi:10.1093/jn/135.1.58 · Cited by 25
Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia
Jarvik, G. P., Beaty, T. H., Gallagher, P. R., Coates, P. M., & Cortner, J. A. (1993) · Genetic Epidemiology · doi:10.1002/gepi.1370100406 · Cited by 25
Pioglitazone reduces atherogenic dense low density lipoprotein (LDL) particles in patients with type 2 diabetes mellitus
Winkler, K., Friedrich, I., Baumstark, M. W., Wieland, H., & März, W. (2002) · The British Journal of Diabetes · doi:10.1177/14746514020020021301 · Cited by 25
Plasma Phospholipid Transfer Protein Activity Is Decreased in Type 2 Diabetes During Treatment With Atorvastatin
Dallinga‐Thie, G. M., van Tol, A., Hattori, H., Rensen, P. C. N., Sijbrands, E. J. G., & for the Diabetes Atorvastatin Lipid Intervention (DALI) Study Group (2006) · Diabetes · doi:10.2337/db05-1685 · Cited by 26
“An atherogenic lipoprotein profile, characterized by increased plasma levels of triglycerides, decreased levels of HDL cholesterol, and presence of small dense LDL particles, is a major determinant, although the exact underlying molecular mechanisms remain to be established (3).”
Background
Lipid Metabolism and Health
Moffatt, R. J., & STAMFORD, B. A. (2005) · CRC Press eBooks · doi:10.1201/9781420038422 · Cited by 25
Circulating microRNA-126 &122 in patients with coronary artery disease: Correlation with small dense LDL
Mishra, S., Rizvi, A., Pradhan, A. K., Perrone, M. A., & Ali, W. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106536 · Cited by 25
MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?
Byrne, C. D., & Targher, G. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.06 · Cited by 24
The nuances of atherogenic dyslipidemia in diabetes: Focus on triglycerides and current management strategies
Manoria, P. C., Chopra, H. K., Parashar, S.-R., Dutta, A. L., Pinto, B., Mullasari, A., & Prajapati, S. (2013) · Indian Heart Journal · doi:10.1016/j.ihj.2013.10.015 · Cited by 27
Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events
Pauciullo, P., Gentile, M., Marotta, G., Baiano, A., Ubaldi, S., Jossa, F., Iannuzzo, G., Faccenda, F., Panico, S., & Rubba, P. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.004 · Cited by 24
Dyslipidemia and Food Security in Low-Income US Adolescents: National Health and Nutrition Examination Survey, 2003–2010
Tester, J. M., Laraia, B. A., Leung, C. W., & Mietus‐Snyder, M. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.150441 · Cited by 24
“In particular, increased consumption of added sugar is a contributor to atherogenic dyslipidemia, increasing TGs and cardiovascular disease risk (26); more research is needed to clarify differences in the dietary intake of adolescents with marginal food security compared with their peers.”
Long term excessive Zn-supplementation promotes metabolic syndrome-X in Wistar rats fed sucrose and fat rich semisynthetic diet.
Taneja, S. K., Mandal, R., & Girhotra, S. (2006) · PubMed · Cited by 24
Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment
Morales‐Palomo, F., Ramírez-Jiménez, M., ORTEGA, J. F., Moreno‐Cabañas, A., & Mora‐Rodríguez, R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz304 · Cited by 24
Microchip‐based small, dense low‐density lipoproteins assay for coronary heart disease risk assessment
Wang, H., Wang, H., Jin, Q., Cong, H., Zhuang, G., Zhao, J., Sun, C., Song, H., & Wang, W. (2008) · Electrophoresis · doi:10.1002/elps.200700631 · Cited by 24
HDL Composition Regulates Displacement of Cell Surface‐Bound Hepatic Lipase
Rouhani, N., Young, E. K., Chatterjee, C., & Sparks, D. L. (2008) · Lipids · doi:10.1007/s11745-008-3214-1 · Cited by 24
Relationship between High-density Lipoprotein-cholesterol and Malondialdehyde-modified Low-density Lipoprotein Concentrations
Kondo, A., Li, J., Manabe, M., Saito, K., Kanno, T., & Maekawa, M. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.72 · Cited by 24
Atorvastatin Reduces Remnant Lipoproteins and Small, Dense Low‐Density Lipoproteins Regardless of the Baseline Lipid Pattern
O’Keefe, J. H., Captain, B. K., Jones, P. G., & Harris, W. S. (2004) · Preventive Cardiology · doi:10.1111/j.1520-037x.2004.03594.x · Cited by 24
A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan
for the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group, Hirata, T., Sugiyama, D., Nagasawa, S.-Y., Murakami, Y., Saitoh, S., Okayama, A., Iso, H., Irie, F., Sairenchi, T., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-016-0203-1 · Cited by 23
“It is, therefore, controversial whether low levels of HDL-C should be a secondary therapeutic target following LDL-C in the prevention of CHD [10–12].”
Influential
A Randomized Study of the Effect of Replacing Sugar-Sweetened Soda by Reduced Fat Milk on Cardiometabolic Health in Male Adolescent Soda Drinkers
Chiu, S., Siri‐Tarino, P. W., Bergeron, N., Suh, J. H., & Krauss, R. M. (2020) · Nutrients · doi:10.3390/nu12020405 · Cited by 26
“4 nm, a size categorized as pattern A, which is characterized by a greater abundance of larger and more buoyant lipoprotein particles and associated with lower CVD risk than a predominance of smaller LDL (pattern B) [11,31].”
BackgroundSelf-citation
Dyslipidemia and coronary artery disease
Kuo, P. T. (1994) · Clinical Cardiology · doi:10.1002/clc.4960171003 · Cited by 23
Genotype by sex interaction in measures of lipids, lipoproteins, and apolipoproteins
Towne, B., Blangero, J., & Siervogel, R. M. (1993) · Genetic Epidemiology · doi:10.1002/gepi.1370100647 · Cited by 23
Treatment of Hypertriglyceridemia: a Review of Current Options
Vrablı́k, M., & Češka, R. (2015) · Physiological Research · doi:10.33549/physiolres.933199 · Cited by 23
Hypertriglyceridemia and Coronary Heart Disease
Oberman, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.6.2098 · Cited by 22
Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients
Suh, S., Park, H., Kim, S. W., Bae, J. C., Tan, A. H.-K., Chung, H. S., Hur, K. Y., Kim, J. H., Kim, K., & Lee, M. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.536 · Cited by 23
“This figure is higher than those observed in previous studies [27,28] and is much higher than that in a report of healthy, non-diabetic Korean adults [29].”
Result
Treatment strategies for management of serum lipids: Lessons learned from lipid metabolism, recent clinical trials, and experience with the HMG CoA reductase inhibitors
Rubenfire, M., COLETTI, A., & Mosca, L. J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80007-8 · Cited by 24
Multiple Metabolic Syndrome: Aspects of Genetic Epidemiology and Molecular Genetics
Kesäniemi, Y. A., Lilja, M., Kervinen, K., & Rantala, A. O. (1992) · Annals of Medicine · doi:10.3109/07853899209166996 · Cited by 23
A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors
Barnes, J. F., FARISH, E., Rankin, M., & Hart, D. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00560-3 · Cited by 23
A randomized, controlled trial on the effects of almonds on lipoprotein response to a higher carbohydrate, lower fat diet in men and women with abdominal adiposity
Williams, P. T., Bergeron, N., Chiu, S., & Krauss, R. M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1025-4 · Cited by 22
“High plasma concentrations of small LDL particles and triglyceride, and low HDL-cholesterol concentrations define atherogenic dyslipidemia [8].”
BackgroundSelf-citation
Health benefits of polyunsaturated fatty acids (PUFAs)
Minihane, A. M., & Lovegrove, J. A. (2006) · Elsevier eBooks · doi:10.1533/9781845691073.1.107 · Cited by 23
Adiponectin and sE-selectin Concentrations in Relation to Inflammation in Obese Type 2 Diabetic Patients With Coronary Heart Disease
EL-Mesallamy, H. O., Hamdy, N. Μ., Salman, T. M., & Ibrahim, S. M. (2011) · Angiology · doi:10.1177/0003319711408587 · Cited by 22
Low HDL cholesterol is associated with increased atherogenic lipoproteins and insulin resistance in women classified with metabolic syndrome
Fernández, M. L., Jones, J. J., Ackerman, D., Barona, J., Calle, M. C., Comperatore, M., Kim, J., Andersen, C. J., Leite, J. O. M., Volek, J. S., et al. (2010) · Nutrition Research and Practice · doi:10.4162/nrp.2010.4.6.492 · Cited by 22
“The phenotype characterized by a predominance of small LDL particles has been termed pattern B and is typical of MetS and diabetes [27].”
Background
Insulin and lipoprotein metabolism with special reference to the diabetic state
TOMKIN, G. H., & Owens, D. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100303 · Cited by 22
Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players
Yates, A. P., Norwig, J. A., Maroon, J. C., Bost, J. W., Bradley, J. P., Duca, M. A., Wecht, D. A., Grove, R., Iso, A., Cobb, I., et al. (2009) · Sports Health A Multidisciplinary Approach · doi:10.1177/1941738108326978 · Cited by 23
“Low-density lipoprotein size correlates positively with plasma HDL levels and negatively with plasma triglyceride concentrations.(3,17) The combination of small dense LDL, decreased HDL cholesterol, and increased triglycerides has been coined by Austin et al(3) in 1990 as the “atherogenic lipoprotein phenotype.”
Background
Lipid abnormalities in the metabolic syndrome
Brinton, E. A. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0056-3 · Cited by 22
Genetic, Metabolic, and Dietary Influences on the Atherogenic Lipoprotein Phenotype
Krauss, R. M. (1997) · KARGER eBooks · doi:10.1159/000059581 · Cited by 22
Self-citation
Preserved Antilipolytic Insulin Action Is Associated with a Less Atherogenic Plasma Lipid Profile in Healthy Centenarians
Paolisso, G., Gambardella, A., Ammendola, S., Tagliamonte, M. R., Rizzo, M. R., Capurso, A., & Varricchio, M. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb03203.x · Cited by 22
Low-density lipoprotein heterogeneity
Griffin, B. A. (1995) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80065-4 · Cited by 22
Therapeutic modulation of low-density lipoprotein size
Marais, A. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00005 · Cited by 22
Influence of n-3 fatty acids from fish oils on concentration of high- and low-density lipoprotein subfractions and their lipid and apolipoprotein composition
Baumstark, M. W., Frey, I., Berg, A., & Keul, J. (1992) · Clinical Biochemistry · doi:10.1016/0009-9120(92)80012-6 · Cited by 22
Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin
Baldassarre, S., Scruel, O., Deckelbaum, R. J., Dupont, I. E., Ducobu, J., & Carpentier, Y. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.006 · Cited by 22
Lipoprotein classes and coronary disease regression
Zambon, A., & Hokanson, J. E. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199808000-00008 · Cited by 22
Effect of berries/apple mixed juice consumption on the positive modulation of human lipid profile
Habánová, M., Saraiva, J. A., Holovičová, M., Moreira, S. A., Fidalgo, L. G., Habán, M., Gažo, J., Schwarzová, M., Chlebo, P., & Bronkowska, M. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103417 · Cited by 22
The HMG‐CoA Reductase Gene and Lipid and Lipoprotein Levels: the Multi‐Ethnic Study of Atherosclerosis
Chen, Y., Chen, Y. I., Li, X., Post, W., Herrington, D., Polak, J. F., Rotter, J. I., & Taylor, K. D. (2009) · Lipids · doi:10.1007/s11745-009-3314-6 · Cited by 21
“Atherogenic lipoprotein phenotype was demonstrated to segregate in Caucasian families [6], and heritability of LDL particles was estimated to range from 0.”
Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size
van Schalkwijk, D. B., de Graaf, A. A., van Ommen, B., van Bochove, K., Rensen, P. C. N., Havekes, L. M., van de Pas, N. C. A., Hoefsloot, H. C. J., van der Greef, J., & Freidig, A. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800354-jlr200 · Cited by 21
High disaccharide intake associates with atherogenic lipoprotein profile
Sonestedt, E., Wirfält, E., Wallström, P., Gullberg, B., Drake, I., Hlebowicz, J., Fredrikson, G. N., Hedblad, B., Nilsson, J. Å., Krauss, R. M., et al. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003783 · Cited by 21
Self-citation

Authors: Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M.
Affiliations: University of California, Berkeley (US)
ORCID: King, M C
Krauss, R M
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1990-08
Volume: 82
Issue: 2
Pages: 495-506
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.82.2.495
OpenAlex: W2089286420
Cited by: 1,411
References: 63
Citations by year: 2026: 11 · 2025: 15 · 2024: 17 · 2023: 39 · 2022: 20 · 2021: 26 · 2020: 25 · 2019: 27 · 2018: 17 · 2017: 21 · 2016: 27 · 2015: 42 · 2014: 38 · 2013: 46 · 2012: 39
FWCI: 47.63
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Energy (DE-AC03-?, AC03-76SF00098, DEAC03-76SF00098)
National Institutes of Health (7r29hl038760-03, 5p01hl018574-26, DE-AC03- 76SF00098)
National Heart, Lung, and Blood Institute (HL38760, HL-18574)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: atherogenic lipoprotein phenotype, LDL subclasses, low-density lipoprotein, coronary heart disease risk, genetic markers, single-gene inheritance, apolipoprotein B, apolipoprotein A-I, HDL cholesterol, HDL2, triglycerides, VLDL, intermediate density lipoprotein
MeSH terms: Adolescent, Adult, Aged, Arteriosclerosis, Child, Child, Preschool, Chromosome Mapping, Coronary Disease, Female, Genetic Markers, Humans, Lipids, Lipoproteins, Cholesterol, HDL, Male, Middle Aged, Phenotype, Risk Factors, Triglycerides, Multivariate Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks